Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions

Publikation: Beitrag in Fachzeitschrift (peer-reviewed)Artikel in Fachzeitschrift

Abstract

♦ BACKGROUND: Intraperitoneal administration of antimicrobial agents is recommended for the treatment of peritoneal dialysis (PD)-related peritonitis. For home-based antimicrobial therapy it is common to supply patients with PD fluid bags with admixed antibiotic. Thus, the compatibility of meropenem with different PD fluids (PDFs), namely Extraneal, Physioneal 1.36% and Physioneal 2.27% (all Baxter Healthcare Corp., Deerfield, IL, USA), was investigated under varying storage conditions. ♦ METHODS: Meropenem (Venus Pharma, Werne, Germany) was stored at 6°C and 25°C over 14 days and at 37°C over 24 hours. Drug concentration over time was determined using high performance liquid chromatography, drug activity by a diffusion disk method, diluent stability by visual inspection and drug adsorption was calculated. Blank PD fluids and deionized water were used as comparator solutions. ♦ RESULTS: Compared to water, the stability of meropenem was minimally lower in Extraneal but markedly reduced in both Physioneal solutions. No significant drug adsorption was detected for any PDF investigated. ♦ CONCLUSIONS: Meropenem is stable and compatible with Extraneal and might be stored for up to a week at refrigeration temperature (6°C). A loss of ~20% of meropenem after 2 days at room temperature should be considered. Mixed Physioneal appears not suitable for storage at any temperature after meropenem has been admixed. A considerable drug degradation due to the warming up to body temperature through heating plates should further be taken into account in clinical practice.

OriginalspracheEnglisch
Seiten (von - bis)51-55
Seitenumfang5
FachzeitschriftPeritoneal Dialysis International
Jahrgang37
Ausgabenummer1
DOIs
PublikationsstatusVeröffentlicht - 2017
Extern publiziertJa

Fingerprint

Untersuchen Sie die Forschungsthemen von „Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren